Extension Study of BG00012 in Pediatric Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)
NCT02555215
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Sclerosis, Relapsing-Remitting
Interventions
DRUG:
dimethyl fumarate
Sponsor
Biogen